IADR Abstract Archives

Porphyromonas gingivalis gingipain propeptides inhibit gingipains and bacterial growth

Porphyromonas gingivalis, the main pathogen that causes chronic periodontitis in adults, secretes outer membrane cysteine proteinases, the Arg-specific proteinases (RgpA, RgpB/Arg-gingipains) and the Lys-specific proteinase (Kgp/Lys-gingipain) that are its main virulence factors. Inhibition of these proteinases using specific inhibitors is an important therapeutic strategy to prevent or treat this chronic disease. Many proteinases are synthesized as inactive precursors with propeptides that inhibit proteinase function.

Objectives: This study aims to characterize the inhibitory potential of Kgp and RgpB propeptides against the mature cognate enzymes.

Methods: Mature Kgp was purified from a P. gingivalis Kgp adhesin-binding domain (ABM1) mutant which releases the Kgp catalytic domain (KgpcatΔABM1) into the culture supernatant, allowing simpler purification. Purification of KgpcatΔABM1 and RgpB from P. gingivalis strain HG66 was carried out at pH 5.3 to prevent enzyme degradation. Recombinant propeptides of Kgp and RgpB were produced in Escherichia coli and purified using nickel-affinity chromatography. The propeptides were incubated with the purified KgpcatΔABM1 or RgpB with chromogenic or fluorescent substrates to monitor proteolytic activity. P. gingivalis growth assays were conducted in a protein-based medium.

Results: Both propeptides exhibited selectivity towards their cognate enzyme with 60-90% inhibition at an enzyme:inhibitor concentration of 1:10 with the rRgpB propeptide displaying stronger inhibitory activity. The rKgp and rRgpB propeptides displayed competitive inhibition kinetics with a Ki of 2.3 mM and 9 nM, respectively. Their specificity for the gingipains was demonstrated by their inability to inhibit papain, a closely related cysteine proteinase. Both propeptides at 100 mg/L caused a 50% reduction of P. gingivalis growth in the protein based medium.

Conclusions: Gingipain propeptides are capable of inhibiting mature gingipains; therefore the development of specific small peptide inhibitors based on cognate propeptide sequences may be a viable therapeutic strategy against pathogenic bacteria that rely on proteolytic activity for virulence.

Australian/New Zealand Division Meeting
2012 Australian/New Zealand Division Meeting (Denarau Island, Fiji)
Denarau Island, Fiji
2012

Scientific Groups
  • Toh, Elena  ( University of Melbourne, Oral Health CRC, Melbourne, N/A, Australia )
  • Huq, Laila  ( University of Melbourne, Melbourne, VIC, Australia )
  • Seers, Christine  ( The University of Melbourne, Melbourne, N/A, Australia )
  • Dashper, Stuart  ( The University of Melbourne, Carlton, N/A, Australia )
  • Meuric, Vincent  ( Université de Rennes 1, Rennes, N/A, France )
  • Ward, Brent  ( University of Melbourne, Melbourne, N/A, Australia )
  • Cross, Keith  ( University of Melbourne, Carlton, N/A, Australia )
  • Reynolds, Ec  ( The University of Melbourne, Carlton, N/A, Australia )
  • Periodontal Research